AT
TEVA icon

Arlington Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Arlington Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12K Hold
92
– – ﹤0.01% 611
2026
Q1 		$2.77K Buy
+92
New +$2.96K ﹤0.01% 613
2024
Q1 		– Sell
-214
Closed -$2.23K – 850
2023
Q4 		$2.23K Buy
+214
New +$2K ﹤0.01% 610

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Arlington Trust's TEVA Position: Q2 2026 in Review

Arlington Trust held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 92 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Arlington Trust first reported a position in TEVA in Q4 2023 and has held it in 3 quarters since. 89 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Arlington Trust held 92 shares of Teva Pharmaceuticals worth $3.12K as of Q2 2026.
  • Arlington Trust left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #611 holding.
  • Arlington Trust first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • 89 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.